Guangdong Tai'an Tang Pharmaceutical Co., Ltd. announced the appointment of Southwest Securities Co., Ltd. as its sponsor broker following a qualified audit report for the fiscal year after receiving a delisting risk warning. The decision was made during the board meeting on June 19, 2024, to facilitate stock transfer services and related matters. Further announcements regarding stock registration and custody procedures will be made separately.
Summary generated by AI · Always verify with source document
Guangdong Tai'an Tang Pharmaceutical Co., Ltd. announces the appointment of a sponsor broker. The company and all members of the board guarantee that the content of the information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.